Short Interest in Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Declines By 48.2%

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) saw a large decline in short interest in March. As of March 15th, there was short interest totalling 415,800 shares, a decline of 48.2% from the February 28th total of 803,100 shares. Approximately 0.0% of the company's stock are sold short. Based on an average trading volume of 1,625,800 shares, the short-interest ratio is currently 0.3 days.

Bayer Aktiengesellschaft Stock Down 2.0 %

Shares of BAYRY traded down $0.12 during midday trading on Tuesday, reaching $6.02. The stock had a trading volume of 412,980 shares, compared to its average volume of 913,257. The company has a market cap of $23.66 billion, a price-to-earnings ratio of -23.15 and a beta of 1.02. The company's fifty day simple moving average is $5.96 and its two-hundred day simple moving average is $6.10. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.32 and a quick ratio of 0.81. Bayer Aktiengesellschaft has a 1-year low of $4.79 and a 1-year high of $8.58.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.